NIKA PHARMACEUTICALS, INC - 13 Apr 2022 Form 4 Insider Report for NIKA PHARMACEUTICALS, INC (NIKA)

Role
President, CEO, CFO, Director, 10%+ Owner
Signature
Savov Dimitar Slavchev
Issuer symbol
NIKA
Transactions as of
13 Apr 2022
Net transactions value
+$29,999,999,727,868
Form type
4
Filing time
19 Mar 2024, 14:08:45 UTC
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKPH Preferred A Stock Other $30,000,000,000,000 +10,000,000 $3000000.00* 10,000,000 13 Apr 2022 Direct F1, F2
transaction NKPH Common Purchase $137,868 +11,489,000 $0.0120* $11,489,000 13 Apr 2022 Direct
transaction NKPH Common Other $0 +333,181,000 $0.000000 $344,670,000 20 Jul 2022 Direct F3
transaction NKPH Common Sale $140,000 -7,000,000 $0.0200* $337,670,000 12 Sep 2022 Direct
transaction NKPH Common Sale $25,000 -1,250,000 $0.0200* $336,420,000 26 Sep 2022 Direct
transaction NKPH Common Sale $111,000 -3,000,000 $0.0370* $333,420,000 24 Oct 2022 Direct
transaction NKPH Common Sale $63,000 -6,300,000 $0.0100* $327,120,000 10 Jan 2023 Direct
transaction NKPH Common Sale $15,000 -1,500,000 $0.0100* $325,620,000 31 Jan 2023 Direct
transaction NKPH Common Sale $56,000 -3,500,000 $0.0160* $322,120,000 02 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issuance per terms of Exclusive Rights Agreement
F2 Exclusive rights valued at 3,000,000
F3 30-1 forward split as dividend